MiR‐362‐5p is up‐regulated in fresh blood samples of CML cell lines and CML patients and is associated with growth arrest and DNA damage induced (GADD)‐45α down‐regulation and therefore can be used as a downregulator of GADD45α oncomiR, activating JNK1/2 and P38 signal transduction (Yang et al., 2015). The gene discussed is GADD45A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.